What to Expect in Your 2nd Week of Mounjaro

The myth that nothing is 'working' yet in week two

The most widespread misconception about the 2nd week of Mounjaro is that a quiet scale is a failing scale. It isn't. The 2.5 mg starting dose exists specifically to let your gut, appetite system and blood-sugar regulation adjust to a dual GIP and GLP-1 receptor agonist for the first time. The NHS medicines page on tirzepatide is clear that 2.5 mg is a tolerability dose, titrated upward by the prescriber in four-week steps toward the dose where weight loss becomes consistent.

That step-up structure is deliberate. Starting at a higher dose would almost certainly mean a sharper wave of nausea and vomiting, and a greater chance of stopping early. So if your second week feels mild, that is the design working. The job of the first pen is to settle your system. The job of later doses is weight reduction.

In SURMOUNT-1, the large-scale clinical trial published in the New England Journal of Medicine, meaningful average weight loss in the tirzepatide groups accumulated progressively across seventy-two weeks, with the greatest reductions appearing at the higher maintenance doses. If you are in your second week on Mounjaro and seeing no weight loss yet, that places you squarely in the acclimatisation window, not the results window. Comparing your week-two experience to someone else's week-twenty outcome is comparing apples with a completely different fruit.

Side effects that are common in the 2nd week on Mounjaro, and a few worth watching

Nausea is the side effect our prescribers are asked about most weeks, and the second week is often when it peaks for people who felt fine after their first injection. It can arrive a day or two after the dose and settle within days. Loose stools, constipation, indigestion, and a pronounced lack of interest in food are all reported at this stage. None of these require stopping the medicine; they typically ease as the body adjusts.

Staying well hydrated matters more than usual right now. If vomiting or diarrhoea is severe enough to affect how much you can drink, that becomes a more urgent concern because dehydration can affect the kidneys. The NHS recommends contacting a healthcare professional if GI symptoms are persistent or severe. Separately, if you develop severe, persistent stomach pain that radiates toward your back (with or without vomiting) seek medical attention promptly. The MHRA highlighted acute pancreatitis as a known, infrequent but serious effect of GLP-1 medicines in a Drug Safety Update issued in January 2026; knowing the symptom and acting quickly is important.

Injection-site redness or mild itching is also common in early weeks. Rotating between the abdomen, thigh, and upper arm, and using a fresh needle each time, reduces the chance of skin reactions. For the full prescribing detail and storage instructions, the Patient Information Leaflet inside your pen box is the definitive reference.

Appetite changes and what they tell you about week two

Many people on their 2nd week of Mounjaro notice a quieter appetite before they notice any movement on the scale. Food feels less urgent. Portions that used to feel small now feel adequate. This is tirzepatide acting on the gut-hormone pathways that signal fullness, and it is an early sign the medicine is doing what it is designed to do.

The practical risk at this point is eating too little rather than too much. Protein and fluid intake deserve attention: protein helps preserve muscle during weight loss, and dehydration compounds GI side effects. Specific dietary targets are a conversation to have with your prescriber or a registered dietitian, because what is right depends on your starting weight, activity level, and any other health conditions. The week-by-week Mounjaro overview outlines how appetite patterns typically evolve as the dose increases.

A note on alcohol: GLP-1 medicines slow gastric emptying, which can change how quickly alcohol is absorbed. Many people find they feel the effects of alcohol faster than before. This is worth knowing going into week two, not discovering at a dinner table.

What happens after the second week, and how the dose review works

Once four weeks at 2.5 mg are complete, your prescriber will review your progress before any increase. At nume, that review happens before every repeat order (a named clinician reads your answers, not software) and a dose increase requires evidence that you've tolerated the current dose and that moving up is clinically appropriate. The fifth-week period is typically when people move to 5 mg for the first time, and many find that is where appetite suppression becomes more noticeable. By week seven on Mounjaro, patterns begin to emerge that give a clearer picture of how your body is responding over the longer arc. You can read more about those stages in the week six guide.

If you are not yet on treatment and are weighing up your options, the weight-loss treatments page explains how to check your eligibility and start a free consultation. For a broader look at injectable and oral options, the weight-loss overview is a useful starting point. Mounjaro is a prescription-only medicine; a prescriber determines suitability based on your full medical picture, not BMI alone.